SPONSOR CONTENT BY THE BRISTOL-MYERS SQUIBB-PFIZER ALLIANCE

Key information about real-world evidence and treatment decision making

While clinical trial data remains the gold standard for information seekers, decision makers are looking to real-world evidence to complement trial findings and fill knowledge gaps. Real-world data (RWD) analyses can offer new insights that may help address the needs of patients underrepresented in clinical trials, such as the elderly. Though not without limitations, RWD may help inform certain healthcare decisions. Learn more with the BMS-Pfizer Alliance article, Five Facts About RWD.